[HTML][HTML] Efficacy and safety of growth hormone therapy in children with Noonan syndrome
G Sodero, C Cipolla, LC Pane, L Sessa… - Growth Hormone & IGF …, 2023 - Elsevier
Patients with Noonan syndrome typically have a target height< 2 standard deviations
compared to the general population, and half of the affected adults remain permanently …
compared to the general population, and half of the affected adults remain permanently …
Noonan Syndrome Growth Charts and Genotypes: 15-Year Longitudinal Single-Centre Study
M Cappa, F d'Aniello, MC Digilio… - Hormone research in …, 2024 - karger.com
Methods: This was a 15-year-long, monocentric, observational, retrospective, non-
interventional study. Children with NS followed up between 2005 and 2022 at 'Bambino …
interventional study. Children with NS followed up between 2005 and 2022 at 'Bambino …
Noonan Syndrome Growth Charts and Genotypes: 15-Year Longitudinal Single-Centre Study
MCF d'Aniellob, MC Digiliod, MGGC Minottid… - 2024 - karger.com
Abstract Introduction: Growth patterns in Noonan syndrome (NS) remain relatively unknown.
The objective of this study was to provide growth reference curves for patients with NS and …
The objective of this study was to provide growth reference curves for patients with NS and …